All India Institute of Medical Sciences Bhubaneswar, Orissa, India
Pravash R Mishra, MD1, Abhijit Sahu, MSc2, Akansha Das, BSc3, Arun Chaudhury, MD4 1All India Institute of Medical Sciences, Bhubaneswar, Orissa, India; 2All India Institute of Medical Sciences, Bhubaneshwar, Orissa, India; 3Regional Medical Research, Bhubeneswar, Orissa, India; 4Geisinger Wyoming Valley Medical Center, Clarks Summit, PA
Introduction: Diabetes mellitus continues to affect individuals worldwide. Though lifestyle interventions and effective oral and parenteral agents are available, medication side effects and “fear of needles” create challenges in clinical scenario. We examine whether plant extracts of chirayita have the potential to improve diabetes. Use of these herbal product has been mentioned ion the ancient ayurvedic literature.
Methods: Four sets of rats were used in the present study. All studies were conducted after obtaining appropriate permissions per institutional guidelines. Alloxan was used to induce diabetes. Furthermore, hyperglycemia was confirmed using peripheral blood samples. Diabetic animals were treated with either metformin or hydroalcoholic extract obtained from the plant S chirayita. After completed treatments pancreatic tissues were harvested and initially stored in neutral buffered formalin. Tissues that underwent autolytic changes were not included in the study. Immunohistochemical staining with Myosin Va was performed with a primary antibody and chromogenic determination with diaminobenzidine. Islet tissues were examined in the different regions of the pancreas. Image sections were viewed with ImageJ to quantitate protein expression. Further, Fiji was used to render pseudo coloring and mapping of cellular expression of Myosin Va.
Results: The studies demonstrates that Myosin Va expression is lost after induction of diabetes by alloxan in rats, but reversable with metformin and ethnopharmacological agents in chirayita. Biochemical studies revealed improvement of blood glucose levels with metformin and chirayita.
Discussion: The result of the present study demonstrates that Myosin Va expression is lost in chemical diabetes but is reversible with metformin and chirayita extract. Though we have not directly examined the exocytosis of insulin, the expression of Myosin Va may be inferred as a surrogate marker of secretary potential of the β-cells of the islets of Langerhans. Improvement of blood glucose with chirayita may offer adjunct treatment options for type II diabetes mellitus.
Figure: Myosin V a expression control, diabetes and Chirayita treated pancreas
Disclosures:
Pravash R Mishra indicated no relevant financial relationships.
Abhijit Sahu indicated no relevant financial relationships.
Akansha Das indicated no relevant financial relationships.
Arun Chaudhury indicated no relevant financial relationships.
Pravash R Mishra, MD1, Abhijit Sahu, MSc2, Akansha Das, BSc3, Arun Chaudhury, MD4. P0020 - Improvement of Blood Glucose and Recovery of Myosin Va Expression in Pancreatic Islets, ACG 2024 Annual Scientific Meeting Abstracts. Philadelphia, PA: American College of Gastroenterology.